Evidence map›Paper›PMID 20007246›Full record

ArticleJournal of leukocyte biology2010

Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages.

Joseph Brown, Mark A Wallet, Bryan Krastins, David Sarracino, Maureen M Goodenow

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Role of interferons in diabetic retinopathy.World journal of diabetes · 2021
    Review
  5. NRG4-ErbB4 signaling represses proinflammatory macrophage activity.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joseph BrownDepartment of Pathology Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida 32610-3633, USA.
Mark A Wallet
Bryan Krastins
David Sarracino
Maureen M Goodenow

Funding

TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCERT32CA009126 · NCI · UNIVERSITY OF FLORIDA · PI MAY, WILLIAM STRATFORD · 1985 to 2012
$3.5M
IMPACT OF HIV-1 GENOTYPE ON THERAPY RESPONSE IN CHILDRENR01AI047723 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SLEASMAN, JOHN W. · 2001 to 2010
$3.3M
HIV-1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR01HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1995 to 2007
$2.8M
IMMUNOLOGIC/GENETIC MECHANISMS IN RHEUMATIC DISEASEST32AR007603 · NIAMS · UNIVERSITY OF FLORIDA · PI REEVES, WESTLEY H · 1998 to 2014
$2.2M
Role of HIV-1 Env Diversity in Cellular TropismR01AI065265 · NIAID · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 2005 to 2009
$2.1M
NCI NIH HHS CA09126NCI NIH HHS T32 CA009126NIAID NIH HHS AI047723NIAID NIH HHS AI065265NIAID NIH HHS R01 AI047723NIAID NIH HHS R01 AI065265NIAMS NIH HHS T32 AR007603NIAMS NIH HHS T32AR07603NICHD NIH HHS R01 HD032259
6 · The paper itself

Abstract

Macrophage activation is a dynamic process that results in diverse functional outcomes ranging from immunoregulation to inflammation. The proinflammatory, or M1, response is a complex, bimodal progression composed of a "prime," classically through IFN-gamma, and "trigger," such as LPS. To characterize the physiological response of M1 activation, a systems biology approach was applied to determine the intracellular proteome bioprofiles of IFN-gamma-and LPS-treated primary human macrophages. Our goal was to develop intracellular proteomic fingerprints to serve as novel correlates of macrophage priming and/or activation to augment the existing approaches of analyzing secreted cytokines and cell-surface protein expression. The majority of the proteome, approximately 78%, remained stable during activation, representing the core proteome. In contrast, three distinct patterns defined response proteomes: IFN-gamma-specific, LPS-specific, or IFN-gamma- and LPS-shared or M1-specific. Although steady-state expression levels of proteins involved in energy metabolism and immune response were increased during priming and triggering, changes in protein and fatty acid metabolism, signaling, and transport pathways were most apparent. Unique proteomic fingerprints distinguish among IFN-gamma-specific, LPS-specific, or M1-specific activation states and provide a clear molecular, archeological profile to infer recent history of cells, as well as correlates for chronic macrophage activation in health and disease.

Indexed as

Antiviral AgentsCells, CulturedGene Expression RegulationHumansInterferon-gammaLipopolysaccharidesMacrophage ActivationMacrophagesProteomeAntiviral AgentsInterferon-gammaLipopolysaccharidesProteome

Identifiers

PMID20007246
PMCPMC2858305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.